Monte Rosa Therapeutics *
Monte Rosa Therapeutics is a clinical-stage biotechnology company pioneering molecular glue degrader (MGD) medicines. It pairs its QuEEN discovery engine — integrating artificial intelligence, machine learning, and structural biology — with proprietary chemistry to design small molecules that selectively degrade disease-causing proteins previously considered undruggable, across oncology and immunology, with collaborations including Novartis and Roche. Surfaced as a portfolio company of GV and added to the API Evangelist network. The company publishes no public developer API, portal, or documentation; this profile captures its web presence and probed domain-security surface.
Monte Rosa Therapeutics * is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Pharmaceuticals, and Drug Discovery.
Monte Rosa Therapeutics *’s developer surface includes engineering blog and 2 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API